Projects per year
Personal profile
Research Interests
I am an ambitious and compassionate Professor and Honorary Consultant of Clinical Oncology, an international authority in the management of prostate cancer with advanced radiotherapy and systemic therapies. I am a Co-Director for the Belfast Manchester FASTMAN Movember/ Prostate Cancer UK Centre of Excellence programme.
My clinical academic focus is localised and advanced prostate cancer. I am very interested in hypofractionated radiotherapy as a means to escalate radiation dose to tumour and improve outcomes for men with locally advanced prostate cancer. This radiotherapy can be optimally delivered with High Dose Rate brachytherapy or with Image Guided Stereotactic Ablative Radiotherapy (SABR). I am the Chief Investigator on a clinical-translational study of prostate SABR and two studies in prostate cancer. I have been local PI on 17 clinical trials, I'm a member of 9 Trial Mangement Groups.
Translational Research
I collaborate extensively with an interdisciplinary group of academics aimed at modelling modern radiotherapy treatments in vitro and in vivo. We have been comparing different methods of delivering high dose hypofractionated radiotherapy for the treatment of prostate cancer.
I am also interested in biomarkers and the utilisation of nanotechnology to enhance the effects of radiation therapy.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Suneil Jain is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
R6633CNR: ORIGIN: Optical fibRe dose ImaGINg for adaptive brachytherapy
11/11/2019 → …
Project: Research
-
-
R2116CNR: MOVEMBER CENTRE OF EXCELLENCE
O'Sullivan, J., Jain, S., Kennedy, R., McDade, S., Prise, K., Salto-Tellez, M. & Waugh, D.
21/05/2014 → 30/06/2019
Project: Research
-
A randomised feasibility trial of stereotactic prostate radiotherapy with or without elective nodal irradiation in high-risk localised prostate cancer (SPORT Trial)
Houlihan, O. A., Redmond, K., Fairmichael, C., Lyons, C. A., McGarry, C. K., Mitchell, D., Cole, A., O'Connor, J., McMahon, S., Irvine, D., Hyland, W., Hanna, M., Prise, K. M., Hounsell, A. R., O'Sullivan, J. M. & Jain, S., 08 Mar 2023, (Early online date) In: International Journal of Radiation Oncology Biology Physics.Research output: Contribution to journal › Article › peer-review
-
Spatial gene expression changes in the mouse heart after base-targeted irradiation
Walls, G. M., Ghita, M., Queen, R., Edgar, K. S., Gill, E. K., Kuburas, R., Grieve, D. J., Watson, C. J., McWilliam, A., Van Herk, M., Williams, K. J., Cole, A. J., Jain, S. & Butterworth, K. T., 01 Feb 2023, In: International Journal of Radiation Oncology Biology Physics. 115, 2, p. 453-463 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Downloads (Pure) -
Delphi study to identify consensus on patient selection for hydrogel rectal spacer use during radiation therapy for prostate cancer in the UK
Payne, H. A., Jain, S., Peedell, C., Edwards, A., Thomas, J. A., Das, P., Hansson Hedblom, A., Woodward, E., Saunders, R. & Bahl, A., 20 Jul 2022, In: BMJ Open. 12, 7, e060506.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Downloads (Pure) -
Exercise for metastatic castrate-resistant prostate cancer: A feasibility trial in progress during the COVID-19 pandemic (EXACT).
Brown, M., O'Sullivan, J., Jain, S., Murphy, M., McAneney, H. & Prue, G., 01 Jun 2022, In: Supportive Care in Cancer. 30, supplement issue 1, p. S41 1 p., EXERC-02.Research output: Contribution to journal › Meeting abstract › peer-review
-
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial
PACE Trial Investigators, Oct 2022, In: Lancet Oncology. 23, 10, p. 1308-1320Research output: Contribution to journal › Article › peer-review
Prizes
-
3rd Year PhD symposium prize - Charles Haughey
Jain, Suneil (Recipient), 13 Jun 2019
Prize: Other distinction
-
CCRCB Student of the Year - Charles Haughey
Jain, Suneil (Recipient), 13 Jan 2020
Prize: Other distinction
-
FLIMs Methods in Cancer Research
Jain, Suneil (Recipient), 2007
Prize: Fellowship awarded competitively
-
-
Activities
-
2020 National Cancer Research Institute Cancer Conference
Suneil Jain (Organiser)
02 Nov 2020 → 04 Nov 2020Activity: Participating in or organising an event types › Participation in conference
-
Stereotactic radiotherapy with hydrogel spacing
Suneil Jain (Invited speaker)
05 Apr 2020Activity: Talk or presentation types › Invited or keynote talk at national or international conference
-
PGJCCR Open Day
Suneil Jain (Participant)
15 Feb 2020Activity: Participating in or organising an event types › Participation in Festival/Exhibition
-
University of Limerick (External organisation)
Suneil Jain (Advisor)
06 Feb 2020 → 07 Feb 2020Activity: Membership types › Membership of network
-
Advanced radiotherapy for prostate cancer
Suneil Jain (Invited speaker)
04 Feb 2020Activity: Talk or presentation types › Invited or keynote talk at national or international conference
Press/Media
-
Prostate Cancer Centre of Excellence
Suneil Jain, Aidan Cole & Joe O'Sullivan
21/10/2022
1 item of Media coverage
Press/Media: Public Engagement Activities
-
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
10/12/2019
1 Media contribution
Press/Media: Research
-
CT Radiomics in Prostate Cancer
28/09/2019 → 01/12/2019
1 item of Media coverage, 1 Media contribution
Press/Media: Public Engagement Activities
-
Belfast trials aim for improved prostate cancer treatment
08/08/2018
1 item of Media coverage
Press/Media: Research
-
Prostate cancer treatment breakthrough at Queen's University of Belfast
08/08/2018
1 item of Media coverage
Press/Media: Research